| Investigating the zoonotic origin of the West African Ebola epidemic A Marí Saéz, S Weiss, K Nowak, V Lapeyre, F Zimmermann, A Düx, ... EMBO molecular medicine 7 (1), 17-23, 2015 | 536 | 2015 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 509 | 2016 |
| Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients C Kreer, M Zehner, T Weber, MS Ercanoglu, L Gieselmann, C Rohde, ... Cell 182 (4), 843-854. e12, 2020 | 374 | 2020 |
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ... The Lancet Infectious Diseases 15 (10), 1156-1166, 2015 | 319 | 2015 |
| A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ... New England Journal of Medicine 374 (17), 1635-1646, 2016 | 302 | 2016 |
| Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography TAM Bharat, T Noda, JD Riches, V Kraehling, L Kolesnikova, S Becker, ... Proceedings of the National Academy of Sciences 109 (11), 4275-4280, 2012 | 289 | 2012 |
| Marburg virus evades interferon responses by a mechanism distinct from ebola virus C Valmas, MN Grosch, M Schümann, J Olejnik, O Martinez, SM Best, ... PLoS pathogens 6 (1), e1000721, 2010 | 191 | 2010 |
| Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial T Koch, C Dahlke, A Fathi, A Kupke, V Krähling, NMA Okba, S Halwe, ... The Lancet Infectious Diseases 20 (7), 827-838, 2020 | 167 | 2020 |
| Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells TAM Bharat, JD Riches, L Kolesnikova, S Welsch, V Krähling, N Davey, ... PLoS biology 9 (11), e1001196, 2011 | 167 | 2011 |
| Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity V Krähling, DA Stein, M Spiegel, F Weber, E Mühlberger Journal of virology 83 (5), 2298-2309, 2009 | 132 | 2009 |
| Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV A Rechtien, L Richert, H Lorenzo, G Martrus, B Hejblum, C Dahlke, ... Cell reports 20 (9), 2251-2261, 2017 | 122 | 2017 |
| Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV SA Ehrhardt, M Zehner, V Krähling, H Cohen-Dvashi, C Kreer, N Elad, ... Nature medicine 25 (10), 1589-1600, 2019 | 108 | 2019 |
| Electron tomography reveals the steps in filovirus budding S Welsch, L Kolesnikova, V Krähling, JD Riches, S Becker, JAG Briggs PLoS pathogens 6 (4), e1000875, 2010 | 91 | 2010 |
| Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein … S Pfefferle, V Krähling, V Ditt, K Grywna, E Mühlberger, C Drosten Virology journal 6, 1-17, 2009 | 84 | 2009 |
| Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study A Huttner, ST Agnandji, C Combescure, JF Fernandes, EB Bache, ... The Lancet Infectious Diseases 18 (7), 738-748, 2018 | 83 | 2018 |
| Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization C Dahlke, R Kasonta, S Lunemann, V Krähling, ME Zinser, N Biedenkopf, ... EBioMedicine 19, 107-118, 2017 | 81 | 2017 |
| Functional characterization of adaptive mutations during the West African Ebola virus outbreak E Dietzel, G Schudt, V Krähling, M Matrosovich, S Becker Journal of virology 91 (2), 10.1128/jvi. 01913-16, 2017 | 74 | 2017 |
| Establishment of Fruit Bat Cells (Rousettus aegyptiacus) as a Model System for the Investigation of Filoviral Infection V Krähling, O Dolnik, L Kolesnikova, J Schmidt-Chanasit, I Jordan, ... PLoS neglected tropical diseases 4 (8), e802, 2010 | 73 | 2010 |
| Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: a phase I randomised trial ST Agnandji, JF Fernandes, EB Bache, RM Obiang Mba, JS Brosnahan, ... PLoS medicine 14 (10), e1002402, 2017 | 67 | 2017 |
| Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells M Hölzer, V Krähling, F Amman, E Barth, SH Bernhart, VAO Carmelo, ... Scientific reports 6 (1), 34589, 2016 | 64 | 2016 |
